Bousarghin L - Search Results

1

Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.

Renoux VM, Fleury MJ, Bousarghin L, Gaitan J, Sizaret PY, Touzé A, Coursaget P. Renoux VM, et al. Among authors: bousarghin l. Vaccine. 2008 Dec 2;26(51):6602-7. doi: 10.1016/j.vaccine.2008.09.035. Vaccine. 2008. PMID: 18835319

2

Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.

Bousarghin L, Touzé A, Yvonnet B, Coursaget P. Bousarghin L, et al. J Med Virol. 2004 Jul;73(3):474-80. doi: 10.1002/jmv.20114. J Med Virol. 2004. PMID: 15170645

3

Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.

Bousarghin L, Touze A, Gaud G, Iochmann S, Alvarez E, Reverdiau P, Gaitan J, Jourdan ML, Sizaret PY, Coursaget PL. Bousarghin L, et al. Mol Cancer Ther. 2009 Feb;8(2):357-65. doi: 10.1158/1535-7163.MCT-08-0626. Epub 2009 Jan 27. Mol Cancer Ther. 2009. PMID: 19174559

4

Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells.

Touzé A, Bousarghin L, Ster C, Combita AL, Roingeard P, Coursaget P. Touzé A, et al. Among authors: bousarghin l. J Gen Virol. 2001 Dec;82(Pt 12):3005-3009. doi: 10.1099/0022-1317-82-12-3005. J Gen Virol. 2001. PMID: 11714977

5

Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.

Bousarghin L, Combita-Rojas AL, Touzé A, El Mehdaoui S, Sizaret PY, Bravo MM, Coursaget P. Bousarghin L, et al. J Clin Microbiol. 2002 Mar;40(3):926-32. doi: 10.1128/JCM.40.3.926-932.2002. J Clin Microbiol. 2002. PMID: 11880418 Free PMC article.

6

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Combita AL, Touzé A, Bousarghin L, Christensen ND, Coursaget P. Combita AL, et al. Among authors: bousarghin l. J Virol. 2002 Jul;76(13):6480-6. doi: 10.1128/jvi.76.13.6480-6486.2002. J Virol. 2002. PMID: 12050360 Free PMC article.

7

Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor.

Bousarghin L, Touzé A, Combita-Rojas AL, Coursaget P. Bousarghin L, et al. J Gen Virol. 2003 Jan;84(Pt 1):157-164. doi: 10.1099/vir.0.18789-0. J Gen Virol. 2003. PMID: 12533712

8

The nine C-terminal amino acids of the major capsid protein of the human papillomavirus type 16 are essential for DNA binding and gene transfer capacity.

Touzé A, Mahé D, El Mehdaoui S, Dupuy C, Combita-Rojas AL, Bousarghin L, Sizaret PY, Coursaget P. Touzé A, et al. Among authors: bousarghin l. FEMS Microbiol Lett. 2000 Aug 1;189(1):121-7. doi: 10.1111/j.1574-6968.2000.tb09217.x. FEMS Microbiol Lett. 2000. PMID: 10913877

9

Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.

Combita AL, Touzé A, Bousarghin L, Sizaret PY, Muñoz N, Coursaget P. Combita AL, et al. Among authors: bousarghin l. FEMS Microbiol Lett. 2001 Oct 16;204(1):183-8. doi: 10.1111/j.1574-6968.2001.tb10883.x. FEMS Microbiol Lett. 2001. PMID: 11682199

10

Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells.

Bousarghin L, Touzé A, Sizaret PY, Coursaget P. Bousarghin L, et al. J Virol. 2003 Mar;77(6):3846-50. doi: 10.1128/jvi.77.6.3846-3850.2003. J Virol. 2003. PMID: 12610160 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters